Medifast Q3 2023 Adj EPS $2.12 Beats $1.06 Estimate, Sales $235.87M Beat $232.10M Estimate
Portfolio Pulse from saritha@benzinga.com
Medifast reported Q3 2023 earnings of $2.12 per share, beating the analyst consensus estimate of $1.06 by 100%. However, this is a 36.14% decrease from the same period last year. The company also reported quarterly sales of $235.87 million, beating the estimate of $232.10 million by 1.62%, but this is a 39.58% decrease from the same period last year.
November 06, 2023 | 9:18 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Medifast's Q3 2023 earnings and sales beat estimates, but both showed a significant decrease from the same period last year.
While Medifast beat analyst estimates for Q3 2023, the significant decrease in both earnings and sales compared to the same period last year could potentially offset any positive impact from beating estimates. This could lead to a neutral short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100